BNP Paribas Financial Markets Buys Shares of 13,437 TruBridge, Inc. (NASDAQ:TBRG)

BNP Paribas Financial Markets purchased a new position in TruBridge, Inc. (NASDAQ:TBRG) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 13,437 shares of the company’s stock, valued at approximately $161,000. BNP Paribas Financial Markets owned approximately 0.09% of TruBridge as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in TBRG. GSA Capital Partners LLP purchased a new position in TruBridge during the third quarter valued at $389,000. GAMMA Investing LLC purchased a new position in shares of TruBridge in the 3rd quarter worth about $26,000. Oppenheimer Asset Management Inc. bought a new position in TruBridge in the 3rd quarter worth about $309,000. CacheTech Inc. purchased a new stake in TruBridge during the 3rd quarter valued at about $2,875,000. Finally, Cubist Systematic Strategies LLC bought a new stake in TruBridge during the 2nd quarter valued at about $740,000. Hedge funds and other institutional investors own 88.64% of the company’s stock.

Analysts Set New Price Targets

TBRG has been the topic of several analyst reports. Royal Bank of Canada reiterated an “outperform” rating and issued a $14.00 target price on shares of TruBridge in a research note on Tuesday, September 17th. Barclays upped their price objective on TruBridge from $10.00 to $14.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th. Stephens lifted their target price on TruBridge from $13.00 to $17.00 and gave the stock an “equal weight” rating in a report on Wednesday, November 20th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $13.00 price target on shares of TruBridge in a report on Friday, October 4th.

Insider Buying and Selling at TruBridge

In other news, major shareholder Pinetree Capital Ltd. purchased 3,997 shares of the business’s stock in a transaction on Wednesday, October 2nd. The stock was acquired at an average cost of $11.93 per share, for a total transaction of $47,684.21. Following the purchase, the insider now directly owns 603,997 shares in the company, valued at $7,205,684.21. This trade represents a 0.67 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Mark V. Anquillare acquired 2,500 shares of the stock in a transaction dated Monday, November 25th. The stock was acquired at an average price of $16.81 per share, for a total transaction of $42,025.00. Following the purchase, the director now directly owns 17,178 shares in the company, valued at approximately $288,762.18. This trade represents a 17.03 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 3.60% of the company’s stock.

TruBridge Stock Up 1.3 %

Shares of TruBridge stock opened at $18.09 on Wednesday. TruBridge, Inc. has a twelve month low of $7.55 and a twelve month high of $18.80. The company has a quick ratio of 1.78, a current ratio of 1.80 and a debt-to-equity ratio of 1.00. The company’s 50 day moving average is $15.14 and its 200 day moving average is $12.66. The company has a market cap of $269.99 million, a price-to-earnings ratio of -4.42, a price-to-earnings-growth ratio of 70.25 and a beta of 0.69.

About TruBridge

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.